1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Severe intestinal vasculitis in a patient under treatment with bortezomib

Mangiacavalli, S., Zappasodi, P., Castagnola, C., Astori, C., Varettoni, M., Lazzarino, M. & Corso, A., 2007, In : Annals of Hematology. 86, 12, p. 923-924 2 p.

Research output: Contribution to journalArticle

2008

DCEP chemotherapy followed by a single, fixed dose of pegylated filgrastim allows adequate stem cell mobilization in multiple myeloma patients

Zappasodi, P., Nosari, A. M., Astori, C., Ciapanna, D., Bonfichi, M., Varettoni, M., Mangiacavalli, S., Morra, E., Lazzarino, M. & Corso, A., May 2008, In : Transfusion. 48, 5, p. 857-860 4 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 841-843 3 p.

Research output: Contribution to journalArticle

Efficacy of Bortezomib followed by local irradiation in two patients with extramedullary plasmacytomas.

Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Lazzarino, M. & Corso, A., May 2008, In : Leukemia Research. 32, 5, p. 839-841 3 p.

Research output: Contribution to journalArticle

Immune-mediated neuropathies in myeloma patients treated with bortezomib

Ravaglia, S., Corso, A., Piccolo, G., Lozza, A., Alfonsi, E., Mangiacavalli, S., Varettoni, M., Zappasodi, P., Moglia, A., Lazzarino, M. & Costa, A., Nov 2008, In : Clinical Neurophysiology. 119, 11, p. 2507-2512 6 p.

Research output: Contribution to journalArticle

Infiltration of the spinal cord in a patient with multiple myeloma

Varettoni, M., Corso, A., Zappasodi, P., Calliada, F., Castagnola, C., Mangiacavalli, S. & Lazzarino, M., 2008, In : Journal of Clinical Oncology. 26, 25, p. 4207-4209 3 p.

Research output: Contribution to journalArticle

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy

Corso, A., Mangiacavalli, S., Barbarano, L., Montalbetti, L., Mazzone, A., Fava, S., Varettoni, M., Zappasodi, P., Morra, E. & Lazzarino, M., Jul 2008, In : Leukemia Research. 32, 7, p. 1085-1090 6 p.

Research output: Contribution to journalArticle

The place of thalidomide in the treatment of multiple myeloma

Corso, A. & Mangiacavalli, S., Feb 2008, In : Oncology Reviews. 1, 4, p. 205-214 10 p.

Research output: Contribution to journalArticle

2009

A striking response to bortezomib in a patient with pleural localization of multiple myeloma

Mangiacavalli, S., Varettoni, M., Zappasodi, P., Pica, G., Lazzarino, M. & Corso, A., Apr 2009, In : Leukemia Research. 33, 4, p. 577-578 2 p.

Research output: Contribution to journalArticle

Bortezomib plus dexamethasone is highly effective in relapsed and refractory myeloma patients but responses are short-lived

Corso, A., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Pica, G. M., Algarotti, A., Pascutto, C. & Lazzarino, M., Nov 2009, In : European Journal of Haematology. 83, 5, p. 449-454 6 p.

Research output: Contribution to journalArticle

Considerations in the treatment of multiple myeloma: A consensus statement from Italian experts

Patriarca, F., Petrucci, M. T., Bringhen, S., Baldini, L., Caravita, T., Corradini, P., Corso, A., Di Raimondo, F., Falcone, A., Ferrara, F., Morabito, F., Musto, P., Offidani, M., Petrini, M., Rizzi, R., Semenzato, G., Tosi, P., Vacca, A., Cavo, M., Boccadoro, M. & 1 others, Palumbo, A., Feb 2009, In : European Journal of Haematology. 82, 2, p. 93-105 13 p.

Research output: Contribution to journalArticle

Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients

Mangiacavalli, S., Pica, G., Varettoni, M., Lazzarino, M. & Corso, A., Mar 2009, In : European Journal of Haematology. 82, 3, p. 240-241 2 p.

Research output: Contribution to journalArticle

High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: Results of a global phase 3b expanded access program

Mikhael, J. R., Belch, A. R., Prince, H. M., Lucio, M. N., Maiolino, A., Corso, A., Petrucci, M. T., Musto, P., Komarnicki, M. & Stewart, A. K., Jan 2009, In : British Journal of Haematology. 144, 2, p. 169-175 7 p.

Research output: Contribution to journalArticle

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects

Corso, A., Zappasodi, P., Barbarano, L., Petrucci, M. T., Palumbo, A., Caravita, T., Mangiacavalli, S., Cafro, A. M., Varettoni, M., Gay, F., Morra, E. & Lazzarino, M., Sep 2009, In : Leukemia Research. 33, 9

Research output: Contribution to journalArticle

2010

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Harousseau, J. L., Dimopoulos, M. A., Wang, M., Corso, A., Chen, C., Attal, M., Spencer, A., Yu, Z., Olesnyckyj, M., Zeldis, J. B., Knight, R. D. & Weber, D. M., Oct 2010, In : Haematologica. 95, 10, p. 1738-1744 7 p.

Research output: Contribution to journalArticle

Bortezomib plus dexamethasone can improve stem cell collection and overcome the need for additional chemotherapy before autologous transplant in patients with myeloma

Corso, A., Barbarano, L., Mangiacavalli, S., Spriano, M., Alessandrino, E. P., Cafro, A. M., Pascutto, C., Varettoni, M., Bernasconi, P., Grillo, G., Carella, A. M., Montalbetti, L., Lazzarino, M. & Morra, E., Feb 2010, In : Leukemia and Lymphoma. 51, 2, p. 236-242 7 p.

Research output: Contribution to journalArticle

Changing pattern of presentation in monoclonal gammopathy of undetermined significance: A single-center experience with 1400 patients

Varettoni, M., Corso, A., Cocito, F., Mangiacavalli, S., Pascutto, C., Zappasodi, P., Pica, G. & Lazzarino, M., Jul 2010, In : Medicine (United States). 89, 4, p. 211-216 6 p.

Research output: Contribution to journalArticle

Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: A longitudinal study on 1003 consecutive patients

Varettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C. & Lazzarino, M., Feb 2010, In : Annals of Oncology. 21, 2, p. 325-330 6 p.

Research output: Contribution to journalArticle

2012

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jȩdrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., May 10 2012, In : New England Journal of Medicine. 366, 19, p. 1759-1769 11 p.

Research output: Contribution to journalArticle

Risk of second cancers in Waldenström macroglobulinemia

Varettoni, M., Tedeschi, A., Arcaini, L., Pascutto, C., Vismara, E., Orlandi, E., Ricci, F., Corso, A., Greco, A., Mangiacavalli, S., Lazzarino, M. & Morra, E., Feb 2012, In : Annals of Oncology. 23, 2, p. 411-415 5 p.

Research output: Contribution to journalArticle

Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

Mangiacavalli, S., Albani, G., Caravita, T., Cocito, F., Pascutto, C., Zappasodi, P., Bringhen, S., Palumbo, A., Cazzola, M. & Corso, A., Mar 2012, In : Leukemia and Lymphoma. 53, 3, p. 514-515 2 p.

Research output: Contribution to journalArticle

Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Sep 30 2013, In : PLoS One. 8, 9, e75047.

Research output: Contribution to journalArticle

Monoclonal gammopathy of undetermined significance: A new proposal of workup

Mangiacavalli, S., Cocito, F., Pochintesta, L., Pascutto, C., Ferretti, V., Varettoni, M., Zappasodi, P., Pompa, A., Landini, B., Cazzola, M. & Corso, A., Oct 2013, In : European Journal of Haematology. 91, 4, p. 356-360 5 p.

Research output: Contribution to journalArticle

2014

Correction: Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: A cost-effectiveness analysis (PLoS ONE)

Corso, A., Mangiacavalli, S., Cocito, F., Pascutto, C., Ferretti, V. V., Pompa, A., Ciampichini, R., Pochintesta, L. & Mantovani, L. G., Jan 8 2014, In : PLoS One. 9, 1

Research output: Contribution to journalArticle

Psychological care of caregivers, nurses and physicians: a study of a new approach

Abeni, M. S., Magni, M., Conte, M., Mangiacavalli, S., Pochintesta, L., Vicenzi, G., Ferretti, V. V., Pompa, A., Cocito, F., Klersy, C. & Corso, A., Feb 1 2014, In : Cancer Medicine. 3, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

2015

Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study

Oriol, A., Giraldo, P., Kotsianidis, I., Couturier, C., Olie, R., Angermund, R. & Corso, A., Aug 1 2015, In : Hematology. 20, 7, p. 405-409 5 p.

Research output: Contribution to journalArticle

Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM)

Zacchino, M., Bonaffini, P. A., Corso, A., Minetti, V., Nasatti, A., Tinelli, C., Dore, R., Calliada, F. & Sironi, S., Nov 1 2015, In : European Radiology. 25, 11, p. 3382-3389 8 p.

Research output: Contribution to journalArticle

Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

Romano, A., Parrinello, N. L., Consoli, M. L., Marchionni, L., Forte, S., Conticello, C., Pompa, A., Corso, A., Milone, G., Di Raimondo, F. & Borrello, I., Nov 22 2015, In : Annals of Hematology. 94, 11, p. 1875-1883 9 p.

Research output: Contribution to journalArticle

2016

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, G. A. & Morabito, F., Dec 6 2016, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S. S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Jul 12 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice

Jurczyszyn, A., Grzasko, N., Gozzetti, A., Czepiel, J., Cerase, A., Hungria, V., Crusoe, E., Silva Dias, A. L. M., Vij, R., Fiala, M. A., Caers, J., Rasche, L., Nooka, A. K., Lonial, S., Vesole, D. H., Philip, S., Gangatharan, S., Druzd-Sitek, A., Walewski, J., Corso, A. & 31 others, Cocito, F., Vekemans, M. C. M., Atilla, E., Beksac, M., Leleu, X., Davila, J., Badros, A., Aneja, E., Abildgaard, N., Kastritis, E., Fantl, D., Schutz, N., Pika, T., Butrym, A., Olszewska-Szopa, M., Usnarska-Zubkiewicz, L., Usmani, S. Z., Nahi, H., Chim, C. S., Shustik, C., Madry, K., Lentzsch, S., Swiderska, A., Helbig, G., Guzicka-Kazimierczak, R., Lendvai, N., Waage, A., Andersen, K. T., Murakami, H., Zweegman, S. & Castillo, J. J., Jun 1 2016, In : American Journal of Hematology. 91, 6, p. 575-580 6 p.

Research output: Contribution to journalArticle

Implemented myeloma management with whole-body low-dose CT scan: a real life experience

Mangiacavalli, S., Pezzatti, S., Rossini, F., Doni, E., Cocito, F., Bolis, S. & Corso, A., Jan 20 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-7 7 p.

Research output: Contribution to journalArticle

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Oct 21 2016, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Contribution to journalArticle

2017

Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study

Pozzi, S., Gentile, M., Sacchi, S., Marcheselli, R., Corso, A., Cocito, F., Musto, P., Guarini, A., Minoia, C., Vincelli, I., Ria, R., Rivolti, E., Mele, G., Bari, A., Mazzone, C., Badiali, S., Marcheselli, L., Palumbo, A. & Morabito, F., Mar 1 2017, In : Leukemia and Lymphoma. 58, 3, p. 552-559 8 p.

Research output: Contribution to journalArticle

Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial

Bahlis, N. J., Corso, A., Mugge, L. O., Shen, Z. X., Desjardins, P., Stoppa, A. M., Decaux, O., De Revel, T., Granell, M., Marit, G., Nahi, H., Demuynck, H., Huang, S. Y., Basu, S., Guthrie, T. H., Ervin-Haynes, A., Marek, J., Chen, G. & Facon, T., Nov 1 2017, In : Leukemia. 31, 11, p. 2435-2442 8 p.

Research output: Contribution to journalArticle